Optically Guided Needle Biopsy System for Prostate Cancer Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current needle biopsy methods for prostate cancer diagnosis are inefficient, missing approximately 30% of cancerous lesions due to a lack of navigation, and saturation biopsies do not significantly improve sensitivity and specificity.

Innovation Solution

An optically guided needle biopsy system that integrates a motorized computer-controlled probe holder with an ultrasound probe and an optical attachment featuring an optical fiber and biopsy needle, capable of broadband light reflectance spectroscopy and auto-fluorescence lifetime measurement, to accurately locate and differentiate cancerous tissue in real-time.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional needle biopsy methods are used, then the procedure is simple and quick, but the detection accuracy is low and about 30% of cancerous lesions are missed

Engineering Contradiction:
Improvecancer detection accuracyVSAvoidbiopsy system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines ultrasound imaging capability with optical spectroscopy detection into a single integrated biopsy system. The ultrasound probe and optical fiber are integrated into the same catheter assembly, allowing simultaneous anatomical localization and biochemical characterization of tissue, thereby improving cancer detection accuracy while maintaining a unified device structure

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The system performs optical spectroscopy measurements before completing the biopsy procedure. By detecting biochemical signatures of cancerous tissue in real-time during needle insertion, the system identifies target locations preliminarily, allowing the biopsy to focus only on suspicious areas rather than relying on random sampling

Inventive Principle:
Principle #10Preliminary action

2Reliability

If saturation biopsies are performed to improve detection rate, then more tissue samples are taken, but the sensitivity and specificity do not significantly improve and the procedure becomes more invasive

Engineering Contradiction:
Improvediagnosis reliabilityVSAvoidpatient trauma from multiple needle insertions
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The optical spectroscopy system acts as an intermediary between the ultrasound probe and the biopsy needle. It provides real-time biochemical feedback that guides needle positioning, enabling precise targeting of cancerous lesions with minimal needle insertions rather than relying on multiple random samples

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system implements real-time feedback through optical spectroscopy measurements during the biopsy procedure. The detected biochemical signatures are immediately fed back to guide needle positioning and depth, allowing dynamic adjustment to target cancerous tissue accurately and reduce the need for multiple blind insertions

Inventive Principle:
Principle #23Feedback

3Measurement precision

If real-time optical detection is implemented during biopsy, then cancerous tissue can be differentiated with high accuracy, but the device complexity and cost increase

Engineering Contradiction:
Improvetissue differentiation accuracyVSAvoidoptical system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The optical fiber serves multiple functions: it delivers excitation light to the tissue, collects reflected and emitted light signals, and transmits them to the detector. This multi-functionality reduces the need for separate components and simplifies the overall optical system while maintaining high tissue differentiation accuracy

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system uses the patient's own tissue autofluorescence and light scattering properties as the detection mechanism. No external dyes, markers, or contrast agents are required - the tissue itself provides the optical signals needed for cancer detection, eliminating the need for complex delivery systems for external agents

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system enhances the accuracy of prostate cancer diagnosis, reduces under- and over-treatments, and improves patient outcomes by providing a real-time, minimally invasive method for selecting biopsy sites, with high sensitivity and specificity in differentiating cancerous from healthy tissues.

Implementation Method 1

one or more detecting units capable of a broadband light reflectance spectroscopy

Methodology Applied
Scientific EffectLight reflectance spectroscopy: Reflection

Implementation Method 2

one or more detecting units capable of broadband light reflectance spectroscopy, an auto-fluorescence lifetime measurement

Methodology Applied
Scientific EffectAuto-fluorescence: Fluorescence

Data Source

PatentUS9226731B2Optically guided needle biopsy system using multi-modal spectroscopy in combination with a transrectal ultrasound probe
Publication Date: 2016.01.05 BOARD OF RGT THE UNIV OF TEXAS SYST
  • US9226731B2 patent drawing
  • US9226731B2 patent drawing
  • US9226731B2 patent drawing

AI summary

The present invention includes an apparatus, system and method for detection of tissues, e.g., a cancer, by optical biopsy comprising: a motorized computer-controlled probe holder; a needle-like probe connected to and controlled by the motorized computer-controlled probe holder, the probe comprising an optical and an ultrasound detector; and one or more detector units capable of a broadband light reflectance spectroscopy, an auto fluorescence lifetime measurement, and auto fluorescence spectroscopy measurement.